Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cogent Communications
CCOI
$624M
| $20.3M | 0.02% |
318,855
+103,503
| +48% | +$6.66M |
|
|
EFOR
327
Everforth Inc
EFOR
$1.28B
| $20.3M | 0.02% |
245,025
-194,904
| -44% | -$16.9M |
|
328
BioLife Solutions
BLFS
$1.66B
| $20.1M | 0.02% |
925,381
-67,858
| -7% | -$1.53M |
|
329
Varonis Systems
VRNS
$4.87B
| $20.1M | 0.02% |
773,628
+333
| +0% | +$8.68K |
|
330
Take-Two Interactive
TTWO
$43.8B
| $19.7M | 0.02% |
165,242
+18,343
| +12% | +$2.05M |
|
331
Armstrong World Industries
AWI
$7.81B
| $19.4M | 0.02% |
273,018
-62,481
| -19% | -$4.68M |
|
332
Steris
STE
$22.3B
| $19.3M | 0.02% |
100,775
-13,094
| -11% | -$2.53M |
|
333
Freeport-McMoran
FCX
$96.2B
| $18.9M | 0.02% |
463,073
-366
| -0.1% | -$15.2K |
|
334
SolarEdge
SEDG
$2B
| $18.9M | 0.02% |
62,090
+30,147
| +94% | +$9.19M |
|
335
Regal Rexnord
RRX
$12.1B
| $18.9M | 0.02% |
134,024
+2,829
| +2% | +$410K |
|
336
Texas Roadhouse
TXRH
$13.7B
| $18.6M | 0.02% |
171,809
-176,197
| -51% | -$18M |
|
337
Hamilton Lane
HLNE
$5.47B
| $18.5M | 0.02% |
249,658
-39,769
| -14% | -$2.94M |
|
|
TIXT
338
DELISTED
TELUS International
TIXT
| $17.8M | 0.02% |
880,245
-61,859
| -7% | -$1.34M |
|
339
Alibaba
BABA
$302B
| $17.3M | 0.02% |
+169,127
| New | +$16.9M |
|
|
ATVI
340
DELISTED
Activision Blizzard
ATVI
| $17.2M | 0.02% |
201,436
-108,474
| -35% | -$8.43M |
|
341
Biogen
BIIB
$30.2B
| $17.2M | 0.02% |
+61,787
| New | +$17.1M |
|
|
GLDD
342
DELISTED
Great Lakes Dredge & Dock
GLDD
| $17.1M | 0.02% |
3,154,386
-1,124,112
| -26% | -$6.73M |
|
|
MMP
343
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $17M | 0.02% |
314,085
| – | – |
|
344
Hershey
HSY
$36.4B
| $17M | 0.02% |
66,808
-60,033
| -47% | -$14.1M |
|
345
IBM
IBM
$219B
| $16.8M | 0.02% |
128,453
+3,277
| +3% | +$438K |
|
346
Lazard
LAZ
$4.28B
| $16.8M | 0.02% |
508,563
-74,666
| -13% | -$2.75M |
|
347
Sarepta Therapeutics
SRPT
$1.78B
| $16.6M | 0.02% |
+120,261
| New | +$15.6M |
|
348
Array Technologies
ARRY
$891M
| $16.3M | 0.02% |
746,271
+522,345
| +233% | +$10.7M |
|
349
DT Midstream
DTM
$13.6B
| $16.3M | 0.01% |
330,047
-42,586
| -11% | -$2.21M |
|
|
CEQP
350
DELISTED
Crestwood Equity Partners LP
CEQP
| $16.2M | 0.01% |
649,895
+74,211
| +13% | +$1.91M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.